Chia Tai Enterprises International Limited (CAIHF)
OTCMKTS · Delayed Price · Currency is USD
0.2800
+0.2700 (2,700.00%)
At close: May 28, 2025
CAIHF Revenue
Chia Tai Enterprises International had revenue of $107.21M in the quarter ending September 30, 2025, with 71.31% growth. This brings the company's revenue in the last twelve months to $567.72M, up 154.57% year-over-year. In the year 2024, Chia Tai Enterprises International had annual revenue of $307.75M with 76.89% growth.
Revenue (ttm)
567.72M
Revenue Growth
+154.57%
P/S Ratio
0.36
Revenue / Employee
630.80K
Employees
900
Market Cap
206.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 307.75M | 133.77M | 76.89% |
| Dec 31, 2023 | 173.98M | 14.74M | 9.26% |
| Dec 31, 2022 | 159.24M | 16.83M | 11.82% |
| Dec 31, 2021 | 142.41M | 48.83M | 52.18% |
| Dec 31, 2020 | 93.58M | -11.47M | -10.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 423.75M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| MariMed | 157.38M |
| Elite Pharmaceuticals | 122.89M |
| Earth Science Tech | 33.84M |
| Radnostix | 14.07M |
| Healthy Extracts | 3.59M |